Sun Pharma to discontinue non-strategic business units Meghna A Singhania2 Nov 2015 11:08 AM ISTAs a part of its integration process with Ranbaxy Laboratories, Sun Pharma is likely to discontinue certain non-strategic businesses to have a smooth...
Glenmark gets tentative USFDA nod for Lacosamide tablets Meghna A Singhania30 Oct 2015 12:21 PM ISTGlenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its Lacosamide tablets."Glenmark...
Pfizer in merger talks with Botox-maker Allergan: Report Meghna A Singhania30 Oct 2015 10:50 AM ISTPharmaceutical giant Pfizer Inc recently approached Botox-maker Allergan Plc to discuss what could be the biggest takeover deal this year, the Wall...
Hilleman Lab to invest Rs 300 crore to develop vaccines Meghna A Singhania29 Oct 2015 12:54 PM ISTMumbai: Hilleman Laboratories today said it will invest around Rs 300 crore in the next 4-5 years to develop low-cost vaccines to treat diseases like...
Sun Pharma sees huge expansion opportunities in Punjab Meghna A Singhania29 Oct 2015 12:45 PM ISTMohali: Sun Pharma today said it sees immense opportunities for expansion in Punjab even as its focus is on bringing Ranbaxy facilities to...
UFDA approves new product for the treatment of melanoma Meghna A Singhania28 Oct 2015 2:51 PM ISTThe U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the...
Bio Blast Pharma reports promising data on muscle wasting drug Meghna A Singhania28 Oct 2015 12:52 PM ISTBio Blast Pharma Ltd said its lead experimental drug showed signs of being effective in treating patients with a rare muscle wasting disorder, besides...
Bausch + Lomb eyeing expansion to 800 towns Meghna A Singhania28 Oct 2015 11:50 AM ISTMUMBAI: Vision care company Bausch + Lomb, a part of the health and wellness firm, Valeant Pharmaceuticals International is looking to expand its...
Elder Pharma faces tough time, but says will clear all dues Meghna A Singhania27 Oct 2015 12:21 PM ISTMUMBAI: Troubled drugmaker Elder Pharmaceuticals Ltd today said it has been going through tough cash flow situations but asserted it is on the...
Merck's Keytruda extends survival in lung cancer study Meghna A Singhania27 Oct 2015 11:14 AM ISTMerck & Co's approved Keytruda lung cancer treatment provided superior overall survival to chemotherapy in a late-stage study of patients with...
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEXâ„¢ Meghna A Singhania24 Oct 2015 12:36 PM ISTIroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the United...
Genetics help explain poor showing for GSK malaria vaccine Meghna A Singhania23 Oct 2015 8:47 AM ISTLONDON: Scientists have found a genetic explanation for why the world's first malaria vaccine is not very effective in protecting some African...
